SAR443809

N/A

Report date: 2023/03/17 16:23:58

Base Information

Drug NameSAR443809
Drug Alias NameSAR-443809SAR443809
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionComplement factor B inhibitors
TargetsComplement factor B
Therapy Area/IndicationsRare DiseasesHemoglobinuria, Paroxysmal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsRare DiseasesHemoglobinuria, Paroxysmal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A